406 related articles for article (PubMed ID: 19644776)
1. Epigenetic therapeutics in autoimmune disease.
Szyf M
Clin Rev Allergy Immunol; 2010 Aug; 39(1):62-77. PubMed ID: 19644776
[TBL] [Abstract][Full Text] [Related]
2. Prospects for epigenetic compounds in the treatment of autoimmune disease.
Chapman-Rothe N; Brown R
Adv Exp Med Biol; 2011; 711():150-61. PubMed ID: 21627048
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review.
Saito Y; Saito H; Liang G; Friedman JM
Clin Rev Allergy Immunol; 2014 Oct; 47(2):128-35. PubMed ID: 24362548
[TBL] [Abstract][Full Text] [Related]
4. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
Long H; Yin H; Wang L; Gershwin ME; Lu Q
J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics of CD4+ T cells in autoimmune diseases.
Wang Z; Chang C; Lu Q
Curr Opin Rheumatol; 2017 Jul; 29(4):361-368. PubMed ID: 28362657
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional and epigenetic regulation of follicular T-helper cells and their role in autoimmunity.
Qiu H; Wu H; Chan V; Lau CS; Lu Q
Autoimmunity; 2017 Mar; 50(2):71-81. PubMed ID: 28263097
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic therapies in patients with solid tumors: Focus on monotherapy with deoxyribonucleic acid methyltransferase inhibitors and histone deacetylase inhibitors.
Katarzyna R; Lucyna B
J Cancer Res Ther; 2019; 15(5):961-970. PubMed ID: 31603095
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation: A Perfect Combination for Cancer Therapy.
Zahnow CA; Topper M; Stone M; Murray-Stewart T; Li H; Baylin SB; Casero RA
Adv Cancer Res; 2016; 130():55-111. PubMed ID: 27037751
[TBL] [Abstract][Full Text] [Related]
9. MBD2 regulates TH17 differentiation and experimental autoimmune encephalomyelitis by controlling the homeostasis of T-bet/Hlx axis.
Zhong J; Yu Q; Yang P; Rao X; He L; Fang J; Tu Y; Zhang Z; Lai Q; Zhang S; Kuczma M; Kraj P; Xu JF; Gong F; Zhou J; Wen L; Eizirik DL; Du J; Wang W; Wang CY
J Autoimmun; 2014 Sep; 53():95-104. PubMed ID: 24934598
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic control of autoimmune diseases: from bench to bedside.
Picascia A; Grimaldi V; Pignalosa O; De Pascale MR; Schiano C; Napoli C
Clin Immunol; 2015 Mar; 157(1):1-15. PubMed ID: 25576661
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Regulations in Autoimmunity and Cancer: from Basic Science to Translational Medicine.
Hui L; Ziyue Z; Chao L; Bin Y; Aoyu L; Haijing W
Eur J Immunol; 2023 Apr; 53(4):e2048980. PubMed ID: 36647268
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions.
López-Pedrera C; Pérez-Sánchez C; Ramos-Casals M; Santos-Gonzalez M; Rodriguez-Ariza A; Cuadrado MJ
Clin Dev Immunol; 2012; 2012():974648. PubMed ID: 21941583
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation signatures of autoimmune diseases in human B lymphocytes.
Zouali M
Clin Immunol; 2021 Jan; 222():108622. PubMed ID: 33188932
[TBL] [Abstract][Full Text] [Related]
14. Autoreactive B cells and epigenetics.
Renaudineau Y; Garaud S; Le Dantec C; Alonso-Ramirez R; Daridon C; Youinou P
Clin Rev Allergy Immunol; 2010 Aug; 39(1):85-94. PubMed ID: 19644775
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve?
Jeffries MA; Sawalha AH
Expert Rev Clin Immunol; 2015 Jan; 11(1):45-58. PubMed ID: 25534978
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic perspectives on systemic autoimmune disease.
Karagianni P; Tzioufas AG
J Autoimmun; 2019 Nov; 104():102315. PubMed ID: 31421964
[TBL] [Abstract][Full Text] [Related]
17. [The epigenetic alteration and the effect of HDAC inhibitors in multiple myeloma].
Terui Y
Nihon Rinsho; 2015 Jan; 73(1):124-9. PubMed ID: 25626317
[TBL] [Abstract][Full Text] [Related]
18. Targeting epigenetic DNA and histone modifications to treat kidney disease.
Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB
Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238
[TBL] [Abstract][Full Text] [Related]
19. The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases.
Wu H; Chen Y; Zhu H; Zhao M; Lu Q
Front Immunol; 2019; 10():2305. PubMed ID: 31611879
[TBL] [Abstract][Full Text] [Related]
20. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
